Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of the Clinical Outcome Following Treatment Discontinuation After Remission in First-Episode Schizophrenia

NCT00378092 is registered in ClinicalTrials.gov with Janssen Cilag N.V./S.A. as lead sponsor.

NCT NCT00378092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00378092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of the Clinical Outcome Following Treatment Discontinuation After Remission in First-Episode Schizophrenia
Lead sponsor
Janssen Cilag N.V./S.A.
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2006
Completion date
March 31, 2010
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia